# Natesto Testosterone Nasal Gel for Hypogonadal Men

> **NCT05484167** · PHASE4 · WITHDRAWN · sponsor: **University of Utah**

## Conditions studied

- Erectile Dysfunction
- Sexual Dysfunction

## Interventions

- **DRUG:** Natesto Nasal Product
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05484167
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-01
- **Primary completion:** 2024-01-01
- **Final completion:** 2025-04-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** They study lost funding and decided to close the study down.
- **Last updated:** 2022-12-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05484167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05484167, "Natesto Testosterone Nasal Gel for Hypogonadal Men". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05484167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*